We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1044:HKEXDYPNF Co.,Ltd Analysis

Data as of 2026-09-08 - not real-time

HK$21.58

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Hengan International Group Company Limited is bearish at HKD 21.58, with short-term averages lagging the long-term ones. Across the trailing 30 sessions it lost 12.0%. Momentum indicators put RSI at 35.0 (approaching oversold) with MACD reading bearish. Price has been bracketed by support at HKD 20.86 and resistance at HKD 24.92.
Valuation screens as undervalued, on a P/E of 8.7 with no clean sector comparison available. Analyst price targets sit 19.9% above the current price. Revenue is contracting at 6.1% on a 10.8% profit margin. The 7.49% dividend yield looks covered by current payout levels.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 30.6%, a beta of -0.07 and a maximum drawdown of 28.0%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 3/10 conviction over the longer horizon.

Top Market Events

The goal of this article is to teach you how to use price to earnings ratios P/E ratios .Hengan International Group Company Limited HKG:1044 is a stock with outstanding fundamental characteristics.Today we'll evaluate Hengan International Group Company Limited HKG:1044 to determine whether it could have.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 26.20
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 26.20
  • Analyst targets imply +19.9% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Analyst targets imply +19.9% versus the current price
  • Revenue contracting at -6.1%
  • P/E ratio of 8.7

Key Metrics & Analysis

Financial Health

Revenue Growth-6.10%
Profit Margin10.81%
P/E Ratio8.7
ROE11.09%
ROA4.30%
Debt/Equity96.77
P/B Ratio1.0
Op. Cash FlowHK$2.2B
Free Cash FlowHK$1.0B

Technical Analysis

TrendBearish
RSI35.0
SupportHK$20.86
ResistanceHK$24.92
MA 20HK$22.72
MA 50HK$23.28
MA 200HK$26.20
MACDBearish
VolumeDecreasing
Fear & Greed Index93.95

Valuation

Fair ValueHK$12.21
Target PriceHK$25.87
Upside/Downside19.87%
GradeUndervalued
TypeValue
Dividend Yield7.49%

Risk Assessment

Beta-0.07
Volatility30.61%
Sector RiskLow
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.